Our team has previously reported on the utility of markers such as albumin‐to‐globulin ratio,26 lymphocyte‐to‐CRP ratio7 and modified Glasgow prognostic scale27 in CRC. The gene discussed is ALB; the disease is colorectal carcinoma.